SEC Form 4 reporting owner

Walters Group

Walters Group has filed 2 Form 4 transactions reported between December 31, 2025 and August 14, 2026, as 10% owner of Zentalis Pharmaceuticals, Inc..

Name as filed: WALTERS GROUP

Open-market buys, 24 mo

$22.9M

2 lines

Open-market sales, 24 mo

None

reported

Companies

with Form 4 filings

Latest transaction

Aug 14, 2026

transaction date

Roles and reported holdings

ZNTLZentalis Pharmaceuticals, Inc.
Dec 31, 2025 – Aug 14, 2026
10% owner
Held directly17,844,973 sh as of Aug 14, 2026 · Form 4
24 months: $22.9M bought

Transaction history

All 2 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

Date	Company	Type	Shares	Price	Value	Owned after	Filing
Aug 14, 2026	ZNTL10% owner	Open-market purchaseCode P · direct	4,335,000	$3.50	$15.2M@ $3.50	17,844,973	Form 4
Dec 31, 2025	ZNTL10% owner	Open-market purchaseCode P · direct	6,459,973	$1.20	$7.8M@ $1.20	13,509,973	Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.